Navigation Links
KaloBios' KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology
Date:9/18/2013

.
  • KB001-A, an anti-PcrV mAb fragment, is partnered exclusively with Sanofi and is being developed for the prevention and treatment of Pa infection. KaloBios has retained rights for the CF indication and has initiated a 180 patient Phase 2 study in CF subjects with chronic Pa lung infection in the United States. KaloBios received Orphan Drug Status from the European Commission regarding its applications for KB001-A for the treatment of Pa lung infection in CF. Sanofi is pursuing a ventilator-associated pneumonia prevention indication in the intensive care setting, an indication which has received U.S. FDA Fast Track Designation.
  • KB004, an anti-EphA3 mAb, has potential in treating hematologic malignancies and solid tumors. KaloBios is currently testing this drug in a Phase 1 study in subjects with hematologic malignancies.
  • All of the company's antibodies were generated using its proprietary Humaneered® technology, a method that converts nonhuman antibodies (typically mouse) into recombinant antibodies that have a high binding affinity to their target and are designed for chronic therapeutic use. The company believes that antibodies produced using its Humaneered® technology offer important clinical and economic advantages over antibodies generated by other methods in terms of high binding affinity, high manufacturing yields, and minimal to no immunogenicity (inappropriate immune response) upon repeat administration in humans.

    For more information on KaloBios Pharmaceuticals, please visit our web site at http://www.kalobios.com.

    Forward Looking Statements

    This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's clinical development of KB001-
    '/>"/>

    SOURCE KaloBios Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
    2. KaloBios Pharmaceuticals Completes Initial Public Offering
    3. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
    4. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
    5. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
    6. KaloBios to Present at Future Leaders in the Biotech Industry Conference
    7. KaloBios Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
    8. KaloBios to Present at Needham Healthcare Conference
    9. KaloBios Reports First Quarter 2013 Financial Results
    10. KaloBios to Present at Stifel Healthcare Conference 2013
    11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... MIRAGE, Calif. , Aug. 20, 2014 The ... named Fernando Davila has been successfully treated for ... disease", by Dr, Anibal R. Gauto , Medical Director ... Center, at Eisenhower Medical Center in Rancho Mirage, ... new treatment pioneered by Dr. John Crew at ...
    (Date:8/20/2014)... 20, 2014 Research and Markets ... "Global Advanced Wound Care and Closure Market (Types, ... Global Trends, Company Profiles, Demand, Insights, Analysis, Research, ... report to their offering. ... and closure market (types, applications, end user and ...
    (Date:8/20/2014)... PHOENIX , Aug. 20, 2014 /PRNewswire-USNewswire/ ... next-generation sequencing and proteomic diagnostics and biomarker driven ... collaboration with TESARO, Inc.  Paradigm will use its ... from clinical trials to better predict which patients ... may lead to more successful clinical trial outcomes ...
    Breaking Medicine Technology:Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 2Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 3Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 4Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 5Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' 6Global Advanced Wound Care and Closure Market (Types, Applications, End User and Geography) - Forecast to 2020 2Paradigm Announces Molecular Profiling Collaboration with TESARO, Inc. 2
    (Date:8/20/2014)... 20, 2014 Locating rates for insurance packages ... Quotes Pros website. A new source of term life insurance ... rates good for all 50 states at http://quotespros.com/life-insurance.html . ... of the new methods available for the public to find ... are supplied. The instant quotations that are available are good ...
    (Date:8/20/2014)... HealthDay Reporter WEDNESDAY, Aug. 20, 2014 ... the past two decades, plummeting 57 percent and saving taxpayers ... estimated 4 million fewer births occurred among teenagers as a ... Centers for Disease Control and Prevention. That "eye-opening" reduction ... Bill Albert, chief program officer of The National Campaign to ...
    (Date:8/20/2014)... women underwent breast reconstruction following a mastectomy for ... included being black, having a lower education level ... of the Memorial Sloan Kettering Cancer Center, New ... and Cancer Rights Act in 1998 guaranteed insurance ... most women who undergo a mastectomy do not ...
    (Date:8/20/2014)... Opinion: The time to deploy Ebola vaccines is now, ... vaccines is now, according to a commentary being published ... Medicine . The authors from Yale School of ... geographic dissemination of the current Ebola outbreak represent a ... under current efforts. Several Ebola vaccines have been developed ...
    (Date:8/20/2014)... Barbara Bronson Gray HealthDay Reporter ... extremely rare, colds, flu and other minor infections might ... stroke in children, a new study suggests. Just five ... the United States, said Dr. Heather Fullerton, lead author of ... the University of California, San Francisco Benioff Children,s Hospital. "It ...
    Breaking Medicine News(10 mins):Health News:Term Life Insurance Price Database Now Helps Quote Prices for Adults in 50 States Online 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 2Health News:Teen Birth Rate Has Dropped Dramatically in Last Two Decades: CDC 3Health News:Patient perspectives on breast reconstruction following mastectomy 2Health News:News from Annals of Internal Medicine 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3
    ... BLOOMINGTON, Ind. -- Findings reported today (Aug. 5) from ... prayer for another person,s healing just might help -- ... person being prayed for. Candy Gunther Brown, ... at Indiana University Bloomington, led the study of "proximal ...
    ... for better vaccines and ways to deliver them, a ... new approach to boosting the body,s response to vaccinations. ... molecules used in drugs that treat diabetes also stimulate ... make antibodies for protection against invading microorganisms. The ...
    ... , WEDNESDAY, Aug. 4 (HealthDay News) -- Low cellular levels ... aggressive breast cancers, new research suggests. Testing levels of ... doctors better predict which breast cancers will return and which ... had a hint that iron might be important in cancer ...
    ... Wednesday, Aug. 4, 2010 A new study by ... soon help to spare some women with breast cancer from ... Investigators found that low levels of ferroportin, the ... with the most aggressive and recurring cancers. The finding suggests ...
    ... Oncology (ASTRO) has released evidence-based guidelines to define ... that hypofractionated (HF) WBI is effective for many ... published in the International Journal of Radiation ... Studies have shown that WBI following breast conserving ...
    ... identified a new mechanism that controls the number of hematopoietic ... and immune system cells. In a report in the ... of Sciences , researchers from Massachusetts General Hospital (MGH) and ... that increases the number of these blood stem cells, an ...
    Cached Medicine News:Health News:Study finds proximity could be key to success of healing prayer 2Health News:Study finds proximity could be key to success of healing prayer 3Health News:Study finds proximity could be key to success of healing prayer 4Health News:UR discovers new way to boost vaccines, seeks patent 2Health News:A New Marker to Spot Aggressive Breast Cancers? 2Health News:Iron-regulating protein is strong predictor of breast cancer prognosis, study shows 2Health News:Iron-regulating protein is strong predictor of breast cancer prognosis, study shows 3Health News:ASTRO publishes whole breast irradiation guidelines 2Health News:MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment 2
    The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
    Stryker Endoscopy has combined a standardized pressurizing system with an advanced hand piece design that is lightweight and compact in order to streamline laparoscopic procedures....
    The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
    ... to disintegrate renal and ureteral ... technology in a compact design ... and affordable lithotripsy system. The ... of clinical results for both ...
    Medicine Products: